0001878332-23-000001.txt : 20231122 0001878332-23-000001.hdr.sgml : 20231122 20231121191427 ACCESSION NUMBER: 0001878332-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231121 EFFECTIVENESS DATE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reservoir Neuroscience, Inc. CENTRAL INDEX KEY: 0001878332 IRS NUMBER: 841945362 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-497920 FILM NUMBER: 231429638 BUSINESS ADDRESS: STREET 1: 6460 HOLLIS ST, SUITE A CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 507-304-0565 MAIL ADDRESS: STREET 1: 6460 HOLLIS ST, SUITE A CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001878332 Reservoir Neuroscience, Inc. 6460 HOLLIS ST, SUITE A EMERYVILLE CA CALIFORNIA 94608 507-304-0565 DELAWARE None None Corporation true 2019 Aaron Friedman 6460 Hollis St. Suite A Emeryville CA CALIFORNIA 94608 Executive Officer Director Vladimir Senatorov 6460 Hollis St. Suite A Emeryville CA CALIFORNIA 94608 Executive Officer Director Patrick Burgermeister 6460 Hollis St. Suite A Emeryville CA CALIFORNIA 94608 Director Brian Slingerland 6460 Hollis St. Suite A Emeryville CA CALIFORNIA 94608 Director James Summers 6460 Hollis St. Suite A Emeryville CA CALIFORNIA 94608 Director Biotechnology Decline to Disclose 06b false 2023-11-14 false true false 0 4099998 2099999 1999999 Amount includes shares of preferred stock issued upon conversion of $100,000 of SAFEs. The amount also reflects the first tranche of the offering. The investors will acquire the remaining amounts in a second tranche following the initial closing date. false 7 0 0 0 false Reservoir Neuroscience, Inc. /s/ Aaron Friedman Aaron Friedman CEO 2023-11-21